Bladder Urothelial Cancer
3 clinical trials · Condition
◉ Watch Bladder Urothelial Cancer
| Record | Firm | Date |
|---|---|---|
| Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors (NCT05311618) | NGM Biopharmaceuticals, Inc | 2022-05-11 |
| Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors (NCT05215574) | NGM Biopharmaceuticals, Inc | 2022-03-31 |
| An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer (NCT04492293) | Beijing InnoCare Pharma Tech Co., Ltd. | 2020-05-27 |
Track Bladder Urothelial Cancer automatically
Every clearance here is in the API, with alerts when new ones post.